{"id":"W2126978426","doi":"10.1007/s00125-010-1804-y","title":"Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials","year":2010,"lang":"en","type":"article","venue":"Diabetologia","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":180,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"GlaxoSmithKline","keywords":"Rosiglitazone; Medicine; Metformin; Internal medicine; Glibenclamide; Diabetes mellitus; Adverse effect; Type 2 diabetes; Sulfonylurea; Clinical trial; Gliclazide; Hazard ratio; Cancer; Endocrinology; Insulin; Confidence interval","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09877667,0.0006282494,0.003066411,0.0008510144,0.0009540792,0.002944984,0.001000571,0.001743882,0.002734899],"category_scores_gemma":[0.1489889,0.000673478,0.003725519,0.0015256,0.001332402,0.002941702,0.002684202,0.002606456,0.0004003543],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009127464,"about_ca_system_score_gemma":0.001116983,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003889157,"about_ca_topic_score_gemma":0.000616841,"domain_scores_codex":[0.848771,0.1111292,0.02070382,0.006563887,0.01137008,0.001461891],"domain_scores_gemma":[0.8289735,0.08329433,0.0687143,0.009723426,0.00557053,0.003723759],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2521768,0.00201939,0.5162987,0.01263802,0.01902038,0.0009944198,0.004406643,0.001336929,0.002178969,0.004972147,0.01823219,0.1657254],"study_design_scores_gemma":[0.1043708,0.06594984,0.7202248,0.004573859,0.02240116,0.007096322,0.001869588,0.003431692,0.003809658,0.008127274,0.05760236,0.0005426236],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8901004,0.07467893,0.00753407,0.00492136,0.0008974763,0.005640964,0.007110904,0.000154125,0.008961785],"genre_scores_gemma":[0.9741799,0.008404199,0.003471948,0.00260169,0.0008178196,0.004127825,0.005002153,0.00004971823,0.001344767],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09877667,"threshold_uncertainty_score":0.5223872,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04647858839311374,"score_gpt":0.3676919514426077,"score_spread":0.321213363049494,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}